LivaNova (LIVN) Cash & Equivalents (2014 - 2026)

LivaNova (LIVN) has 13 years of Cash & Equivalents data on file, last reported at $539.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 26.91% year-over-year to $539.7 million; the trailing twelve-month figure through Mar 2026 stood at $539.7 million (down 26.91% YoY), and the FY2025 full-year result was $635.6 million, up 48.2% from the prior year.
• Cash & Equivalents declined to $539.7 million in Q1 2026, from $635.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $738.4 million in Q1 2025 to a low of $275.2 million in Q3 2022.
• A 5-year average of $381.2 million and a median of $311.4 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents surged 140.93% in 2025 and slipped 26.91% in 2026, its largest moves.
• Tracing LIVN's Cash & Equivalents over 5 years: stood at $301.4 million in 2022, then rose by 3.29% to $311.4 million in 2023, then jumped by 37.73% to $428.9 million in 2024, then surged by 48.2% to $635.6 million in 2025, then dropped by 15.08% to $539.7 million in 2026.
• Business Quant data shows LIVN's Cash & Equivalents at $539.7 million in Q1 2026, $635.6 million in Q4 2025, and $738.4 million in Q1 2025.